Interstitial pulmonary diseases (ILDs), a diverse group of diffuse pulmonary diseases mainly affect pulmonary parenchyma. “OMICS” low-flow “OMICS” technologies (genomics, transcriptomic, proteomics) and relative medications have begun to reshape our understanding of ILLD, while these data are dispersed between massive references...